Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sean Dineen, MD
Moffitt Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Moffitt Cancer Center
Tampa, Florida, United States
Abigail LaPortaAllan Lima Perreira, MDChandler Kracht, PA-CChristopher Ray, PA-CDae Won Kim, MDIman Imanirad, MDJames Nguyen, APRNKara Miller, PA-CKirsten Blue, PA-CMichael Wach, MDMintallah Haider, MDRichard Kim, MDSatish Maharaj, MDSean Dineen, MDTiago Biachi de Castria, MDTiffany Romershausen, MSN, RN, MPHTiffany Valone, PA-CTrenton Avriett, PA-C
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2026
- Primary completion
- 31 Mar 2028
- Completion
- 31 Mar 2028
- Last update posted
- 15 May 2026
- Registered enrollment
- 24
- Registry id
- NCT07487168
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.